Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial
Jennifer J. Knox(National Cancer Center), Grainne M. O’Kane(University College Dublin)
Cited by 21
Related Papers
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
|Journal of Clinical Oncology|2013|830
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
|Clinical Cancer Research|2017|635
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
|Journal of Clinical Oncology|2008|597
Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive Cancer
|New England Journal of Medicine|2025|104